Company Illumina, Inc. Sao Paulo

Equities

I1LM34

BRI1LMBDR007

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Illumina, Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Delayed Sao Paulo Other stock markets 16:35:16 12/06/2024 BST			5-day change	1st Jan Change
120.3 ^BRL	+4.18%		+7.69%	-13.41%

06-11	Evercore ISI Cuts Price Target on Illumina to $175 From $195	MT
06-10	Global markets live: ABB, Roche, Microsoft, Apple, Tesla...

Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows:

- product sales (84.1%): tools and instruments for sequencing, genotyping, genetic expression, etc.;

- sales of services (15.9%).

Net sales are distributed geographically as follows: the United States (52.4%), Americas (3.6%), Europe (25.3%), Asia/Pacific/Middle East/Africa (10.2%) and China/Taiwan/Hong Kong (8.5%).

Number of employees: 10,615

USD in Million	2022	Weight	2023	Weight	Delta
Core Illumina 98.5 %	4,553	99.3 %	4,438	98.5 %	-2.53%
Grail 2.1 %	55	1.2 %	93	2.1 %	+69.09%
Eliminations -0.6 %	-24	-0.5 %	-27	-0.6 %	+12.50%

USD in Million	2022	Weight	2023	Weight	Delta
United States 52.4 %	2,290	50.0 %	2,359	52.4 %	+3.01%
Europe 25.3 %	-	-	1,140	25.3 %	-
Asia-Pacific, Middle East and Africa 10.2 %	418	9.1 %	459	10.2 %	+9.81%
Greater China 8.5 %	472	10.3 %	384	8.5 %	-18.64%
Americas 3.6 %	189	4.1 %	162	3.6 %	-14.29%

Managers	Title	Age	Since
Jacob Thaysen CEO	Chief Executive Officer	49	24/09/23
Steven Barnard CTO	Chief Tech/Sci/R&D Officer	-	31/12/97
Carissa Rollins CTO	Chief Tech/Sci/R&D Officer	54	13/03/22
Kevin Pegels COO	Chief Operating Officer	57	31/10/21
Sallilyn Schwartz IRC	Investor Relations Contact	-	30/11/21
Bryan Crane PRN	Corporate Officer/Principal	-	-
Scott Ericksen AUD	Comptroller/Controller/Auditor	52	31/10/13
Bas Verhoef PRN	Corporate Officer/Principal	-	01-04
Charles Dadswell LAW	General Counsel	65	21/04/13

Members of the board	Title	Age	Since
Robert Epstein BRD	Director/Board Member	58	28/11/12
Stephen MacMillan CHM	Chairman	60	01/06/23
Caroline Dorsa BRD	Director/Board Member	64	26/01/17
Scott Ullem BRD	Director/Board Member	57	01/06/23
Philip Schiller BRD	Director/Board Member	63	27/07/16
Gary Guthart BRD	Director/Board Member	58	30/11/17
Scott Gottlieb BRD	Director/Board Member	51	03/02/20
Susan Siegel BRD	Director/Board Member	63	04/02/19
Frances Arnold BRD	Director/Board Member	67	27/01/16
Jacob Thaysen CEO	Chief Executive Officer	49	24/09/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	199,300,000	158,869,731 ( 79.71 %)	40,000,000 ( 20.07 %)	79.71 %

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 11.45 %	18,245,041	11.45 %	1 903 M R$
BlackRock Advisors LLC 6.463 %	10,295,105	6.463 %	1 074 M R$
STATE STREET CORPORATION 4.276 %	6,812,291	4.276 %	710 M R$
Edgewood Management LLC 4.178 %	6,655,749	4.178 %	694 M R$
Baillie Gifford & Co. 3.601 %	5,736,418	3.601 %	598 M R$
Loomis, Sayles & Co. LP 2.770 %	4,412,277	2.770 %	460 M R$
Geode Capital Management LLC 2.353 %	3,749,045	2.353 %	391 M R$
Janus Henderson Investors US LLC 2.313 %	3,684,585	2.313 %	384 M R$
Eaton Vance Management 2.264 %	3,607,328	2.264 %	376 M R$
WCM Investment Management LLC 2.120 %	3,377,221	2.120 %	352 M R$

Name	Equities	%	Valuation
GRAIL, Inc. 14.65%	98,310,809	14.65%	983 $

Illumina, Inc.

5200 Illumina Way

92122, San Diego

+858 202 4500

http://www.illumina.com

Name	Category and Sector
Illumina Singapore Pte Ltd.
Illumina Cambridge Ltd. Illumina Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services Illumina Cambridge Ltd. develops, manufactures and commercializes instruments, consumables and technologies for the analysis of DNA and genetic variation. The company was founded in 1998 and is headquartered in Saffron Walden, the United Kingdom.	Miscellaneous Commercial Services

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

108.5 USD

Average target price

152.1 USD

Spread / Average Target

+40.17%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+6.86%	220B
DANAHER CORPORATION	+11.71%	196B
INTUITIVE SURGICAL, INC.	+25.73%	152B
BOSTON SCIENTIFIC CORPORATION	+32.55%	114B
SIEMENS HEALTHINEERS AG	+3.08%	66.49B
EDWARDS LIFESCIENCES CORPORATION	+14.31%	52.89B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+1.93%	49.48B
AGILENT TECHNOLOGIES, INC.	-6.02%	38.85B
GE HEALTHCARE TECHNOLOGIES INC.	-1.95%	34.68B

Other Advanced Medical Equipment & Technology